|
Cystine-knot peptides engineered with specificities for αIIbβ3 or αIIbβ3 and αvβ3 integrins are potent inhibitors of platelet aggregation
|
journal
|
May 2010 |
|
Heart Failure Is Not Going Anywhere: Good News, Bad News
|
journal
|
April 2017 |
|
Structure and mechanics of integrin-based cell adhesion
|
journal
|
October 2007 |
|
The Spectrophotometric Determination of Certain Blood Pigments
|
journal
|
October 1932 |
|
Engineered Fibronectin Type III Domain with a RGDWXE Sequence Binds with Enhanced Affinity and Specificity to Human αvβ3 Integrin
|
journal
|
March 2003 |
|
Inhibition of Platelet-Mediated Clot Retraction by Integrin Antagonists
|
journal
|
March 1998 |
|
Integrin Priming Dynamics: Mechanisms of Integrin Antagonist-Promoted αIIbβ3:PAC-1 Molecular Recognition
|
journal
|
August 2009 |
|
A directional switch of integrin signalling and a new anti-thrombotic strategy
|
journal
|
October 2013 |
|
Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα
|
journal
|
May 2017 |
|
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
|
journal
|
March 2002 |
|
Novel antiplatelet agents in acute coronary syndrome
|
journal
|
October 2014 |
|
Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin
|
journal
|
March 2014 |
|
A Novel Regulatory Epitope Defined by a Murine Monoclonal Antibody to the Platelet GPIIb-IIIa Complex (αIIbβ3 Integrin)
|
journal
|
January 1996 |
|
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
|
journal
|
April 2012 |
|
Small-molecule inhibitors of integrin α 2 β 1 that prevent pathological thrombus formation via an allosteric mechanism
|
journal
|
January 2009 |
|
Topography of Ligand-induced Binding Sites, Including a Novel Cation-sensitive Epitope (AP5) at the Amino Terminus, of the Human Integrin Subunit
|
journal
|
May 1995 |
|
Fibrin Clot Retraction by Human Platelets Correlates with αIIbβ3Integrin-dependent Protein Tyrosine Dephosphorylation
|
journal
|
March 2001 |
|
The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen
|
journal
|
April 2016 |
|
Structural basis for distinctive recognition of fibrinogen γC peptide by the platelet integrin α IIb β 3
|
journal
|
August 2008 |
|
Advances in understanding percutaneous coronary intervention pharmacology
|
journal
|
September 2014 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo
|
journal
|
October 2006 |
|
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3
|
journal
|
September 2001 |
|
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 in Complex with an Arg-Gly-Asp Ligand
|
journal
|
March 2002 |
|
Structure-Guided Design of a High-Affinity Platelet Integrin IIb 3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS
|
journal
|
March 2012 |
|
The Roles of Platelet GPIIb/IIIa and αvβ3 Integrins during HeLa Cells Adhesion, Migration, and Invasion to Monolayer Endothelium under Static and Dynamic Shear Flow
|
journal
|
January 2009 |
|
RUC-4: A Novel αIIbβ3 Antagonist for Prehospital Therapy of Myocardial Infarction
|
journal
|
October 2014 |
|
Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis—But Does Not Affect Immunity and Thrombosis in Mice
|
journal
|
November 2011 |
|
Humanized Mouse Model of Thrombosis Is Predictive of the Clinical Efficacy of Antiplatelet Agents
|
journal
|
January 2011 |
|
A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation
|
journal
|
December 2015 |
|
Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia
|
journal
|
February 2017 |
|
Thrombocytopenia following treatment with platelet glycoprotein IIb/IIIa inhibitors
|
journal
|
February 2003 |
|
The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
|
journal
|
October 2008 |
|
Talin-dependent integrin activation is required for fibrin clot retraction by platelets
|
journal
|
February 2011 |
|
Full reconstitution of human platelets in humanized mice after macrophage depletion
|
journal
|
August 2012 |
|
Full activation of mouse platelets requires ADP secretion regulated by SERCA3 ATPase–dependent calcium stores
|
journal
|
August 2016 |
|
Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42
|
journal
|
May 1993 |
|
High Affinity vs. Native Fibronectin in the Modulation of αvβ3 Integrin Conformational Dynamics: Insights from Computational Analyses and Implications for Molecular Design
|
journal
|
January 2017 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
|
Hemodialysis access thrombosis
|
journal
|
December 2017 |
|
Cystine-knot peptides engineered with specificities for αIIbβ3 or αIIbβ3 and αvβ3 integrins are potent inhibitors of platelet aggregation
|
journal
|
May 2010 |
|
Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: Effects of α v β 3 and α IIb β 3 antagonists
|
journal
|
December 2004 |
|
Effects of 2 different antiplatelet regimens with abciximab or tirofiban on platelet function in patients undergoing coronary stenting
|
journal
|
November 2003 |
|
Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjects
|
journal
|
July 1999 |
|
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization11The names and institutions participating in these trials are provided in the appendices of references 1 to 3.
|
journal
|
July 2002 |
|
The Spectrophotometric Determination of Certain Blood Pigments
|
journal
|
October 1932 |
|
Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets
|
journal
|
June 1991 |
|
Engineered Fibronectin Type III Domain with a RGDWXE Sequence Binds with Enhanced Affinity and Specificity to Human αvβ3 Integrin
|
journal
|
March 2003 |
|
Inhibition of Platelet-Mediated Clot Retraction by Integrin Antagonists
|
journal
|
March 1998 |
|
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
|
Interplay of Platelet Contractility and Elasticity of Fibrin/Erythrocytes in Blood Clot Retraction
|
journal
|
February 2017 |
|
Structure and mechanics of integrin-based cell adhesion
|
journal
|
October 2007 |
|
Discovery and antiplatelet activity of a selective PI3Kβ inhibitor (MIPS-9922)
|
journal
|
October 2016 |
|
Integrin Priming Dynamics: Mechanisms of Integrin Antagonist-Promoted αIIbβ3:PAC-1 Molecular Recognition
|
journal
|
August 2009 |
|
Comparative Pharmacology of GP IIb/IIIa Antagonists
|
journal
|
April 2003 |
|
A directional switch of integrin signalling and a new anti-thrombotic strategy
|
journal
|
October 2013 |
|
Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα
|
journal
|
May 2017 |
|
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
|
journal
|
March 2002 |
|
Novel antiplatelet agents in acute coronary syndrome
|
journal
|
October 2014 |
|
Integrin-based therapeutics: biological basis, clinical use and new drugs
|
journal
|
January 2016 |
|
Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin
|
journal
|
March 2014 |
|
A Novel Regulatory Epitope Defined by a Murine Monoclonal Antibody to the Platelet GPIIb-IIIa Complex (αIIbβ3 Integrin)
|
journal
|
January 1996 |
|
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|
journal
|
September 2009 |
|
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
|
journal
|
April 2012 |
|
Small-molecule inhibitors of integrin α 2 β 1 that prevent pathological thrombus formation via an allosteric mechanism
|
journal
|
January 2009 |
|
Topography of Ligand-induced Binding Sites, Including a Novel Cation-sensitive Epitope (AP5) at the Amino Terminus, of the Human Integrin Subunit
|
journal
|
May 1995 |
|
Tyrosine Phosphorylation of the β3 Cytoplasmic Domain Mediates Integrin-Cytoskeletal Interactions
|
journal
|
May 1998 |
|
Fibrin Clot Retraction by Human Platelets Correlates with αIIbβ3Integrin-dependent Protein Tyrosine Dephosphorylation
|
journal
|
March 2001 |
|
The Interaction of Integrin αIIbβ3 with Fibrin Occurs through Multiple Binding Sites in the αIIb β-Propeller Domain
|
journal
|
January 2014 |
|
The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen
|
journal
|
April 2016 |
|
Structural basis for distinctive recognition of fibrinogen γC peptide by the platelet integrin α IIb β 3
|
journal
|
August 2008 |
|
Clot Retraction
|
journal
|
October 1952 |
|
Three-year duration of benefit from abciximab in patient receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study
|
journal
|
October 2005 |
|
Reassignment of a rare sense codon to a non-canonical amino acid in Escherichia coli
|
journal
|
August 2015 |
|
Renal allograft thrombosis
|
journal
|
January 2009 |
|
Correlates of poor outcome among patients with bleeding after coronary interventions
|
journal
|
January 2014 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo
|
journal
|
October 2006 |
|
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3
|
journal
|
September 2001 |
|
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 in Complex with an Arg-Gly-Asp Ligand
|
journal
|
March 2002 |
|
Structure-Guided Design of a High-Affinity Platelet Integrin IIb 3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS
|
journal
|
March 2012 |
|
Comparative In Vitro Efficacy of Different Platelet Glycoprotein IIb/IIIa Antagonists on Platelet-Mediated Clot Strength Induced by Tissue Factor With Use of Thromboelastography: Differentiation Among Glycoprotein IIb/IIIa Antagonists
|
journal
|
April 2000 |
|
Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and α v β 3 Integrins
|
journal
|
September 1998 |
|
RUC-4: A Novel αIIbβ3 Antagonist for Prehospital Therapy of Myocardial Infarction
|
journal
|
October 2014 |
|
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
|
journal
|
March 2017 |
|
Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis—But Does Not Affect Immunity and Thrombosis in Mice
|
journal
|
November 2011 |
|
Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding
|
journal
|
October 2017 |
|
Humanized Mouse Model of Thrombosis Is Predictive of the Clinical Efficacy of Antiplatelet Agents
|
journal
|
January 2011 |
|
Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans
|
journal
|
May 2011 |
|
A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation
|
journal
|
December 2015 |
|
Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia
|
journal
|
February 2017 |
|
Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion
|
journal
|
November 2007 |
|
The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
|
journal
|
October 2008 |
|
Talin-dependent integrin activation is required for fibrin clot retraction by platelets
|
journal
|
February 2011 |
|
Full reconstitution of human platelets in humanized mice after macrophage depletion
|
journal
|
August 2012 |
|
Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
|
journal
|
April 2013 |
|
Full activation of mouse platelets requires ADP secretion regulated by SERCA3 ATPase–dependent calcium stores
|
journal
|
August 2016 |
|
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa
|
journal
|
September 2002 |
|
Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42
|
journal
|
May 1993 |
|
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa
|
journal
|
September 2002 |
|
Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42
|
journal
|
May 1993 |
|
Clot Retraction: Lost in Interpretation?
|
journal
|
January 2019 |
|
High Affinity vs. Native Fibronectin in the Modulation of αvβ3 Integrin Conformational Dynamics: Insights from Computational Analyses and Implications for Molecular Design
|
journal
|
January 2017 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
|
Hemodialysis access thrombosis
|
journal
|
December 2017 |
|
Function and Antagonism of β Integrins in the Development of Cancer Therapy
|
journal
|
June 2009 |
|
Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?
|
journal
|
September 2017 |